FAM53C | Family with sequence similarity 53, member C | | | | | | Expressed in all |
FAM71B | Family with sequence similarity 71, member B | | | | | | Tissue enriched |
FAM81B | Family with sequence similarity 81, member B | | | | | | Group enriched |
FASTKD3 | FAST kinase domains 3 | | | | | | Expressed in all |
FAT2 | FAT atypical cadherin 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
FAXDC2 | Fatty acid hydroxylase domain containing 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FBN2 | Fibrillin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FBXL17 | F-box and leucine-rich repeat protein 17 | Predicted membrane proteins
| | | | | Expressed in all |
FBXO38 | F-box protein 38 | Disease related genes
| | | | | Expressed in all |
FBXW11 | F-box and WD repeat domain containing 11 | Plasma proteins
| | | | | Expressed in all |
FCHO2 | FCH domain only 2 | | | | | | Expressed in all |
FCHSD1 | FCH and double SH3 domains 1 | | | | | | Expressed in all |
FEM1C | Fem-1 homolog c (C. elegans) | | | | | | Expressed in all |
FER | Fer (fps/fes related) tyrosine kinase | Enzymes Plasma proteins
| | | | | Mixed |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FGF18 | Fibroblast growth factor 18 | Cancer-related genes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
FST | Follistatin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FYB | FYN binding protein | | | | | | Tissue enhanced |
G3BP1 | GTPase activating protein (SH3 domain) binding protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
GABRA1 | Gamma-aminobutyric acid (GABA) A receptor, alpha 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GALNT10 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
GAPT | GRB2-binding adaptor protein, transmembrane | | | | | | Tissue enhanced |
GEMIN5 | Gem (nuclear organelle) associated protein 5 | | | | | | Expressed in all |
GFM2 | G elongation factor, mitochondrial 2 | Mitochondrial proteins
| | | | | Expressed in all |
GFPT2 | Glutamine-fructose-6-phosphate transaminase 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GFRA3 | GDNF family receptor alpha 3 | Predicted membrane proteins
| | | | | Mixed |
GLRX | Glutaredoxin (thioltransferase) | Plasma proteins
| | | | | Expressed in all |
GM2A | GM2 ganglioside activator | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GNB2L1 | Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
GNPDA1 | Glucosamine-6-phosphate deaminase 1 | Enzymes
| | | | | Expressed in all |
GOLPH3 | Golgi phosphoprotein 3 (coat-protein) | | | | | | Expressed in all |
GPBP1 | GC-rich promoter binding protein 1 | | | | | | Expressed in all |
GPR150 | G protein-coupled receptor 150 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPRIN1 | G protein regulated inducer of neurite outgrowth 1 | | | | | | Tissue enhanced |
GPX8 | Glutathione peroxidase 8 (putative) | Enzymes
| | | | | Mixed |
GRAMD3 | GRAM domain containing 3 | Predicted membrane proteins
| | | | | Expressed in all |
GRIA1 | Glutamate receptor, ionotropic, AMPA 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes
| | | | | Expressed in all |
GRPEL2 | GrpE-like 2, mitochondrial (E. coli) | Mitochondrial proteins
| | | | | Expressed in all |
H2AFY | H2A histone family, member Y | Plasma proteins
| | | | | Expressed in all |
HAND1 | Heart and neural crest derivatives expressed 1 | Transcription factors
| | | | | Tissue enhanced |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
HARS | Histidyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HARS2 | Histidyl-tRNA synthetase 2, mitochondrial | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HAVCR2 | Hepatitis A virus cellular receptor 2 | Predicted membrane proteins
| | | | | Mixed |
HDAC3 | Histone deacetylase 3 | Enzymes FDA approved drug targets
| | | | | Expressed in all |